These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 28684900)
1. Intranasal agomelatine solid lipid nanoparticles to enhance brain delivery: formulation, optimization and in vivo pharmacokinetics. Fatouh AM; Elshafeey AH; Abdelbary A Drug Des Devel Ther; 2017; 11():1815-1825. PubMed ID: 28684900 [TBL] [Abstract][Full Text] [Related]
2. Agomelatine-based in situ gels for brain targeting via the nasal route: statistical optimization, in vitro, and in vivo evaluation. Fatouh AM; Elshafeey AH; Abdelbary A Drug Deliv; 2017 Nov; 24(1):1077-1085. PubMed ID: 28745530 [TBL] [Abstract][Full Text] [Related]
3. Brain targeting of agomelatine egg lecithin based chitosan coated nanoemulsion. Shukr MH; Farid OAA Pharm Dev Technol; 2021 Apr; 26(4):464-475. PubMed ID: 33586593 [TBL] [Abstract][Full Text] [Related]
4. Formulation of polymeric nanoparticles of antidepressant drug for intranasal delivery. Jani P; Vanza J; Pandya N; Tandel H Ther Deliv; 2019 Nov; 10(11):683-696. PubMed ID: 31744396 [No Abstract] [Full Text] [Related]
5. Brain uptake and accumulation of new levofloxacin-doxycycline combination through the use of solid lipid nanoparticles: Formulation; Optimization and in-vivo evaluation. Abdel Hady M; Sayed OM; Akl MA Colloids Surf B Biointerfaces; 2020 Sep; 193():111076. PubMed ID: 32408259 [TBL] [Abstract][Full Text] [Related]
6. Solid Lipid Nanoparticles Approach for Lymphatic Targeting Through Intraduodenal Delivery of Quetiapine Fumarate. Yasir M; Gaur PK; Puri D; Shehkar P; Kumar SS Curr Drug Deliv; 2018; 15(6):818-828. PubMed ID: 28545354 [TBL] [Abstract][Full Text] [Related]
7. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency. Abd-Elal RM; Shamma RN; Rashed HM; Bendas ER Drug Deliv; 2016 Nov; 23(9):3374-3386. PubMed ID: 27128792 [TBL] [Abstract][Full Text] [Related]
8. Systematic Approach for the Formulation and Optimization of Solid Lipid Nanoparticles of Efavirenz by High Pressure Homogenization Using Design of Experiments for Brain Targeting and Enhanced Bioavailability. Gupta S; Kesarla R; Chotai N; Misra A; Omri A Biomed Res Int; 2017; 2017():5984014. PubMed ID: 28243600 [TBL] [Abstract][Full Text] [Related]
9. Nose to brain delivery of mirtazapine via lipid nanocapsules: Preparation, statistical optimization, radiolabeling, in vivo biodistribution and pharmacokinetic study. Ibrahim MM; Basalious EB; El-Nabarawi MA; Makhlouf AI; Sayyed ME; Ibrahim IT Drug Deliv Transl Res; 2024 Sep; 14(9):2539-2557. PubMed ID: 38376620 [TBL] [Abstract][Full Text] [Related]
10. Effect of binary combinations of solvent systems on permeability profiling of pure agomelatine across rat skin: a comparative study with statistically optimized polymeric nanoparticles. Shinde M; Bali N; Rathod S; Karemore M; Salve P Drug Dev Ind Pharm; 2020 May; 46(5):826-845. PubMed ID: 32312082 [No Abstract] [Full Text] [Related]
12. Development, Optimization, and Evaluation of Carvedilol-Loaded Solid Lipid Nanoparticles for Intranasal Drug Delivery. Aboud HM; El Komy MH; Ali AA; El Menshawe SF; Abd Elbary A AAPS PharmSciTech; 2016 Dec; 17(6):1353-1365. PubMed ID: 26743643 [TBL] [Abstract][Full Text] [Related]
13. Lipid nanoparticles of zaleplon for improved oral delivery by Box-Behnken design: optimization, in vitro and in vivo evaluation. Dudhipala N; Janga KY Drug Dev Ind Pharm; 2017 Jul; 43(7):1205-1214. PubMed ID: 28274147 [TBL] [Abstract][Full Text] [Related]
14. Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington's disease. Bhatt R; Singh D; Prakash A; Mishra N Drug Deliv; 2015; 22(7):931-9. PubMed ID: 24512295 [TBL] [Abstract][Full Text] [Related]
15. Low-Frequency versus High-Frequency Ultrasound-Mediated Transdermal Delivery of Agomelatine-Loaded Invasomes: Development, Optimization and in-vivo Pharmacokinetic Assessment. Tawfik MA; Tadros MI; Mohamed MI; Nageeb El-Helaly S Int J Nanomedicine; 2020; 15():8893-8910. PubMed ID: 33209023 [TBL] [Abstract][Full Text] [Related]
16. Intranasal delivery of Naloxone-loaded solid lipid nanoparticles as a promising simple and non-invasive approach for the management of opioid overdose. Hasan N; Imran M; Kesharwani P; Khanna K; Karwasra R; Sharma N; Rawat S; Sharma D; Ahmad FJ; Jain GK; Bhatnagar A; Talegaonkar S Int J Pharm; 2021 Apr; 599():120428. PubMed ID: 33662465 [TBL] [Abstract][Full Text] [Related]
17. Primary Studies on Construction and Evaluation of Ion-Sensitive in situ Gel Loaded with Paeonol-Solid Lipid Nanoparticles for Intranasal Drug Delivery. Sun Y; Li L; Xie H; Wang Y; Gao S; Zhang L; Bo F; Yang S; Feng A Int J Nanomedicine; 2020; 15():3137-3160. PubMed ID: 32440115 [TBL] [Abstract][Full Text] [Related]
18. Intranasal delivery of doxepin: enhancing brain targeting efficiency utilizing nanostructured lipid carriers for a biopharmaceutics drug disposition classification system class-I drug. Patel HP; Vasandia AV; Jha R; Desai BV; Desai DT; Dedhiya PP; Vyas BA; Maulvi FA Pharm Dev Technol; 2024 Jul; 29(6):639-647. PubMed ID: 38980085 [TBL] [Abstract][Full Text] [Related]
19. Poloxamer-407 thickened lipid colloidal system of agomelatine for brain targeting: Characterization, brain pharmacokinetic study and behavioral study on Wistar rats. Ahmed S; Gull A; Aqil M; Danish Ansari M; Sultana Y Colloids Surf B Biointerfaces; 2019 Sep; 181():426-436. PubMed ID: 31176115 [TBL] [Abstract][Full Text] [Related]
20. Design, optimization and pharmacokinetic evaluation of Piribedil loaded solid lipid nanoparticles dispersed in nasal in situ gelling system for effective management of Parkinson's disease. Uppuluri CT; Ravi PR; Dalvi AV Int J Pharm; 2021 Sep; 606():120881. PubMed ID: 34273426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]